The Phase II Trial of Erotinib and Radiation Therapy Following Chemoradiation Therapy for Patients With Stage III Non-small Cell Lung Cancer has Shown a Favorable Response Profile
2012 ◽
Vol 84
(3)
◽
pp. S68-S69
Keyword(s):
Phase Ii
◽
2010 ◽
Vol 78
(3)
◽
pp. S15
◽